Key Details
Price
$170.89Last Dividend
$1.00Annual ROE
6.03%Beta
0.71Events Calendar
Next earnings date:
Feb 27, 2025Recent quarterly earnings:
Nov 05, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 23, 2012Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents.
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the “Board”), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, “We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
As of Oct. 10, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Activist investor Politan won the two board seats it was seeking at Masimo, defeating founder Joe Kiani and another director at the shareholder vote. Politan nominees Darlene Solomon and Bill Jellison will join two others who were added to the board in a prior proxy fight.
FAQ
- What is the primary business of Masimo?
- What is the ticker symbol for Masimo?
- Does Masimo pay dividends?
- What sector is Masimo in?
- What industry is Masimo in?
- What country is Masimo based in?
- When did Masimo go public?
- Is Masimo in the S&P 500?
- Is Masimo in the NASDAQ 100?
- Is Masimo in the Dow Jones?
- When was Masimo's last earnings report?
- When does Masimo report earnings?
- Should I buy Masimo stock now?